COSTANTINO, GIUSEPPE
COSTANTINO, GIUSEPPE
Azathioprine/6-Mercaptopurine in the treatment of inflammatory bowel disease (IBD)- A single centre experience.
2008-01-01 Costantino, Giuseppe; Sergi, M. D.; Ocera, L.; Lo Presti, M. A.; DELLA TORRE, Anna; Romano, C.; Di Benedetto, A.; Fries, Walter
Clinical practice in the management of ulcerative colitis - an Italian survey
2008-01-01 Fries, Walter; Costa, S; Costantino, Giuseppe; Familiari, Luigi
Effectiveness of Ustekinumab on Crohn‘s Disease Associated Spondyloarthropathy: Real-World Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD)
2020-01-01 Macaluso, F. S.; Fries, W.; Viola, A.; Costantino, G.; Muscianisi, M.; Cappello, M.; Guida, L.; Giuffrida, E.; Magnano, A.; Pluchino, D.; Ferracane, C.; Magri, G.; Di Mitri, R.; Mocciaro, F.; Privitera, A. C.; Camilleri, S.; Garufi, S.; Renna, S.; Casa, A.; Scrivo, B.; Ventimiglia, M.; Orlando, A.
Fecal calprotectin correlates with intestinal permeabilità (IP) in patients with Crohn’s disease.
2006-01-01 Fries, Walter; M. A., Lo Presti; DELLA TORRE, Anna; Costantino, Giuseppe; L., Drago; DI PASQUALE, Giuseppe; G. C., Sturniolo
Ileal tight junction (TJ) alterations associated with experimental colitis – a time course.
2005-01-01 E., Mazzon; Costantino, Giuseppe; DELLA TORRE, Anna; Cuzzocrea, Salvatore; Fries, Walter
Infliximab and etanercept are equally effective in reducing enterocyte apoptosis in experimental colitis.
2008-01-01 Fries, Walter; Muja, C; Crisafulli, Concetta; Costantino, Giuseppe; Longo, Giuseppe; Cuzzocrea, Salvatore; Mazzon, E.
Infliximab normalizes intestinal permeability in the short-term but not fecal calprotectin in Crohn’s disease
2009-01-01 DELLA TORRE, Anna; M. D., Sergi; M. A., Lo Presti; Costantino, Giuseppe; E., Corrente; S., Comunale; R., Pillitteri; M. L., Resta; Fries, Walter
Intestinal gas and liver steatosis: a casual association? A prospective multicentre assessment.
2017-01-01 Maconi, G; Furfaro, F; Fries, W; Dell'Era, A; Bezzio, C; Costantino, G; Giuliano, V; Alibrandi, A; Guzowski, T; Bassotti, G.
Outcome in ulcerative colitis after switch from adalimumab/golimumab to infliximab: A multicenter retrospective study
2019-01-01 Viola, Anna; Pugliese, Daniela; Renna, Sara; Furfaro, Federica; Caprioli, Flavio; D'Incà, Renata; Bossa, Fabrizio; Mazza, Stefano; Costantino, Giuseppe; Fantini, Massimo; Fiorino, Gionata; Alibrandi, Angela; Orlando, Ambrogio; Armuzzi, Alessandro; Fries, Walter
Pan-digestive tract colonization by CMV in Common Variable Immunodeficiency.
2014-01-01 G. Costantino; P. Mondello; M. Previti; W. Fries; V. Villanacci.
Predicting response to thiopurines – a single centre experience.
2011-01-01 Costantino, Giuseppe; F., Furfaro; Alibrandi, Angela; Fries, Walter
Prevention of post-surgical recurrence with adalimumab in a patient with complicated Crohn's disease.
2010-01-01 Costantino, Giuseppe; Navarra, Giuseppe; Familiari, Luigi; Fries, Walter
Response evaluation and safety of thiopurines in the treatment of inflammatory bowel diseases (IBD): safety and response evaluation.
2011-01-01 Costantino, Giuseppe; F., Furfaro; A., Belvedere; Fiorino, Gionata; Alibrandi, Angela; Fries, Walter
Serology of Viral Infections and Tuberculosis Screening in an IBD Population Referred to a Tertiary Centre of Southern Italy
2017-01-01 Ardesia, Marco; Costantino, Giuseppe; Mondello, Placido; Alibrandi, Angela; Fries, Walter
Thalidomide for refractory bleeding small intestinal Crohn’s disease– a case report
2009-01-01 DELLA TORRE, Anna; E., Corrente; S., Comunale; M. A., Lo Presti; M. D., Sergi; R., Pillitteri; Costantino, Giuseppe; Fries, Walter
Therapy-related adverse events in Crohn’s disease (CD) – a comparison between thiopurines, infliximab and combined therapy.
2011-01-01 Fries, Walter; M., Mastronardi; M., Cappello; L., Grossi; F., Furfaro; Costantino, Giuseppe; A., Belvedere; A., Lauria; M., Principi; N., della Valle; N., Buccianti; Alibrandi, Angela; A. C., Privitera
Thiopurine treatment in inflammatory bowel disease: response predictors, safety and withdrawal in follow-up.
2012-01-01 Costantino, Giuseppe; F., Furfaro; Belvedere, Alessandra; Alibrandi, Angela; Fries, Walter
Thiopurines in the treatment of inflammatory bowel diseases – a single centre experience.
2011-01-01 F., Furfaro; Costantino, Giuseppe; Alibrandi, Angela; Fries, Walter
Treatment of life threatening type I refractory celiac disease with long term infliximab
2008-01-01 Costantino, Giuseppe; DELLA TORRE, A.; LO PRESTI, M. A.; Caruso, Rosario; Mazzon, E.; Fries, Walter
Urinary neutrophil gelatinase-associated lipocalin (uNGAL) levels in patients with Crohn’s disease undergoing treatment with infliximab.
2010-01-01 Costantino, Giuseppe; Bolignano, Davide; DELLA TORRE, Anna; M. A., Lo Presti; Lacquaniti, Antonio; Buemi, Michele; Fries, Walter
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Azathioprine/6-Mercaptopurine in the treatment of inflammatory bowel disease (IBD)- A single centre experience. | 1-gen-2008 | Costantino, Giuseppe; Sergi, M. D.; Ocera, L.; Lo Presti, M. A.; DELLA TORRE, Anna; Romano, C.; Di Benedetto, A.; Fries, Walter | |
| Clinical practice in the management of ulcerative colitis - an Italian survey | 1-gen-2008 | Fries, Walter; Costa, S; Costantino, Giuseppe; Familiari, Luigi | |
| Effectiveness of Ustekinumab on Crohn‘s Disease Associated Spondyloarthropathy: Real-World Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD) | 1-gen-2020 | Macaluso, F. S.; Fries, W.; Viola, A.; Costantino, G.; Muscianisi, M.; Cappello, M.; Guida, L.; Giuffrida, E.; Magnano, A.; Pluchino, D.; Ferracane, C.; Magri, G.; Di Mitri, R.; Mocciaro, F.; Privitera, A. C.; Camilleri, S.; Garufi, S.; Renna, S.; Casa, A.; Scrivo, B.; Ventimiglia, M.; Orlando, A. | |
| Fecal calprotectin correlates with intestinal permeabilità (IP) in patients with Crohn’s disease. | 1-gen-2006 | Fries, Walter; M. A., Lo Presti; DELLA TORRE, Anna; Costantino, Giuseppe; L., Drago; DI PASQUALE, Giuseppe; G. C., Sturniolo | |
| Ileal tight junction (TJ) alterations associated with experimental colitis – a time course. | 1-gen-2005 | E., Mazzon; Costantino, Giuseppe; DELLA TORRE, Anna; Cuzzocrea, Salvatore; Fries, Walter | |
| Infliximab and etanercept are equally effective in reducing enterocyte apoptosis in experimental colitis. | 1-gen-2008 | Fries, Walter; Muja, C; Crisafulli, Concetta; Costantino, Giuseppe; Longo, Giuseppe; Cuzzocrea, Salvatore; Mazzon, E. | |
| Infliximab normalizes intestinal permeability in the short-term but not fecal calprotectin in Crohn’s disease | 1-gen-2009 | DELLA TORRE, Anna; M. D., Sergi; M. A., Lo Presti; Costantino, Giuseppe; E., Corrente; S., Comunale; R., Pillitteri; M. L., Resta; Fries, Walter | |
| Intestinal gas and liver steatosis: a casual association? A prospective multicentre assessment. | 1-gen-2017 | Maconi, G; Furfaro, F; Fries, W; Dell'Era, A; Bezzio, C; Costantino, G; Giuliano, V; Alibrandi, A; Guzowski, T; Bassotti, G. | |
| Outcome in ulcerative colitis after switch from adalimumab/golimumab to infliximab: A multicenter retrospective study | 1-gen-2019 | Viola, Anna; Pugliese, Daniela; Renna, Sara; Furfaro, Federica; Caprioli, Flavio; D'Incà, Renata; Bossa, Fabrizio; Mazza, Stefano; Costantino, Giuseppe; Fantini, Massimo; Fiorino, Gionata; Alibrandi, Angela; Orlando, Ambrogio; Armuzzi, Alessandro; Fries, Walter | |
| Pan-digestive tract colonization by CMV in Common Variable Immunodeficiency. | 1-gen-2014 | G. Costantino; P. Mondello; M. Previti; W. Fries; V. Villanacci. | |
| Predicting response to thiopurines – a single centre experience. | 1-gen-2011 | Costantino, Giuseppe; F., Furfaro; Alibrandi, Angela; Fries, Walter | |
| Prevention of post-surgical recurrence with adalimumab in a patient with complicated Crohn's disease. | 1-gen-2010 | Costantino, Giuseppe; Navarra, Giuseppe; Familiari, Luigi; Fries, Walter | |
| Response evaluation and safety of thiopurines in the treatment of inflammatory bowel diseases (IBD): safety and response evaluation. | 1-gen-2011 | Costantino, Giuseppe; F., Furfaro; A., Belvedere; Fiorino, Gionata; Alibrandi, Angela; Fries, Walter | |
| Serology of Viral Infections and Tuberculosis Screening in an IBD Population Referred to a Tertiary Centre of Southern Italy | 1-gen-2017 | Ardesia, Marco; Costantino, Giuseppe; Mondello, Placido; Alibrandi, Angela; Fries, Walter | |
| Thalidomide for refractory bleeding small intestinal Crohn’s disease– a case report | 1-gen-2009 | DELLA TORRE, Anna; E., Corrente; S., Comunale; M. A., Lo Presti; M. D., Sergi; R., Pillitteri; Costantino, Giuseppe; Fries, Walter | |
| Therapy-related adverse events in Crohn’s disease (CD) – a comparison between thiopurines, infliximab and combined therapy. | 1-gen-2011 | Fries, Walter; M., Mastronardi; M., Cappello; L., Grossi; F., Furfaro; Costantino, Giuseppe; A., Belvedere; A., Lauria; M., Principi; N., della Valle; N., Buccianti; Alibrandi, Angela; A. C., Privitera | |
| Thiopurine treatment in inflammatory bowel disease: response predictors, safety and withdrawal in follow-up. | 1-gen-2012 | Costantino, Giuseppe; F., Furfaro; Belvedere, Alessandra; Alibrandi, Angela; Fries, Walter | |
| Thiopurines in the treatment of inflammatory bowel diseases – a single centre experience. | 1-gen-2011 | F., Furfaro; Costantino, Giuseppe; Alibrandi, Angela; Fries, Walter | |
| Treatment of life threatening type I refractory celiac disease with long term infliximab | 1-gen-2008 | Costantino, Giuseppe; DELLA TORRE, A.; LO PRESTI, M. A.; Caruso, Rosario; Mazzon, E.; Fries, Walter | |
| Urinary neutrophil gelatinase-associated lipocalin (uNGAL) levels in patients with Crohn’s disease undergoing treatment with infliximab. | 1-gen-2010 | Costantino, Giuseppe; Bolignano, Davide; DELLA TORRE, Anna; M. A., Lo Presti; Lacquaniti, Antonio; Buemi, Michele; Fries, Walter |